skip to content

Market News

Cambian upgraded by Canaccord

05 December 2016 14:35

Canaccord Genuity has moved to an outright 'buy' recommendation on health services provider Cambian (LON:CMBN) - previously rated as 'speculative buy' - after the group announced the proposed disposal of its adult business along with a special dividend of £40 million.

The broker added: "Catalysts providing upside to our TP could include potentially accretive acquisitions, as the company has signalled its intention to gear the remaining company to 1.5x EBITDA."

Analysts have upped their price target to 150 pence a share from 118 pence.

At 2:35pm: (LON:CMBN) Cambian Group Plc share price was +8.5p at 139.25p

Story provided by StockMarketWire.com

Related Company: CMBN

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.